|
KMID : 1160420220040020068
|
|
Epilia: Epilepsy Commun
2022 Volume.4 No. 2 p.68 ~ p.72
|
|
|
Decitabine-Induced Posterior Reversible Encephalopathy Syndrome in a Patient with Myelodysplastic Syndrome
|
|
Kang Kyung-Wook
Kang You-Ri
Ahn Seo-Yeon
Kim Myeong-Kyu
|
|
|
Abstract
|
|
|
|
Posterior reversible encephalopathy syndrome (PRES) is a neurological disorder characterized by its reversibility both radiologically and clinically, and it typically has a favorable prognosis. Its etiopathogenesis is not clear, although it is known that it involves endothelial dysfunction of the posterior cerebral vasculature, leading to failed cerebral autoregulation. We report a patient with PRES that may have been caused by an immune-mediated response to decitabine.
|
|
|
KEYWORD
|
|
|
Posterior reversible encephalopathy, Decitabine
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|